Atrial fibrillation: The role of common and rare genetic variants

European Journal of Human Genetics

Volumn 22, Issue 3, 2014, Pages 297-306

  Olesen, Morten S ^a,c   Nielsen, Morten W ^a   Haunsø, Stig ^a,b   Svendsen, Jesper H ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

GWAS; lone AF; PITX2

Indexed keywords

ATRIAL FIBRILLATION; GENETIC LOCI; HOMEODOMAIN PROTEINS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTORS;

EID: 84894387715     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2013.139     Document Type: Review

References (128)

1. Go AS, Hylek EM, Phillips KA et al: Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375.
2. Lloyd-Jones D, Adams RJ, Brown TM et al: Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010; 121: 948-954.
3. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D: Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946-952.
4. Psaty BM, Manolio TA, Kuller LH et al: Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455-2461.
5. Fuster V, Rydén LE, Cannom DS et al: ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2011; 57: e101-e198.
6. Mahida S, Lubitz SA, Rienstra M, Milan DJ, Ellinor PT: Monogenic atrial fibrillation as pathophysiological paradigms. Cardiovasc Res 2011; 89: 692-700.
7. Arnar DO, Thorvaldsson S, Manolio TA et al: Familial aggregation of atrial fibrillation in Iceland. Eur Heart J 2006; 27: 708-712.
8. Christophersen IE, Ravn LS, Budtz-Joergensen E et al: Familial aggregation of atrial fibrillation: a study in Danish twins. Circ Arrhythm Electrophysiol 2009; 2: 378-383.
9. Darbar D, Herron KJ, Ballew JD et al: Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol 2003; 41: 2185-2192.
10. Ellinor PT, Yoerger DM, Ruskin JN, MacRae CA: Familial aggregation in lone atrial fibrillation. Hum Genet 2005; 118: 179-184.
11. Fox CS, Parise H, D'Agostino Sr RB, et al: Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004; 291: 2851-2855.
12. Lundby A, Ravn LS, Svendsen JH, Hauns S, Olesen S-P, Schmitt N: KCNE3 mutation V17M identified in a patient with lone atrial fibrillation. Cell Physiol Biochem 2008; 21: 47-54.
13. Ravn LS, Aizawa Y, Pollevick GD et al: Gain of function in IKs secondary to amutation in KCNE5 associated with atrial fibrillation. Heart Rhythm 2008; 5: 427-435.
14. Oyen N, Ranthe MF, Carstensen L et al: Familial aggregation of lone atrial fibrillation in young persons. J Am Coll Cardiol 2012; 60: 917-921.
15. Gudbjartsson DF, Arnar DO, Helgadottir A et al: Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007; 448: 353-357.
16. Benjamin EJ, Rice KM, Arking DE et al: Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet 2009; 41: 879-881.
17. Ellinor PT, Lunetta KL, Glazer NL et al: Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet 2010; 42: 240-244.
18. Ellinor PT, Lunetta KL, Albert CM et al: Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 2012; 44: 670-675.
19. Franco D, Chinchilla A, Aránega AE: Transgenic insights linking pitx2 and atrial arrhythmias. Front Physiol 2012; 3: 206.
20. Kato K, Oguri M, Hibino T et al: Genetic factors for lone atrial fibrillation. Int J Mol Med 2007; 19: 933-939.
21. Chung M, Van Wagoner D, Smith J et al: Significant single nucleotide polymorphism associated with atrial fibrillation located on chromosome 4q25 in a whole genome association study and association with left atrial gene expression. Circulation 2008; 118: S882.
22. Gage PJ, Suh H, Camper SA: Dosage requirement of Pitx2 for development of multiple organs. Development 1999; 126: 4643-4651.
23. Mommersteeg MTM, Brown NA, Prall OWJ et al: Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ Res 2007; 101: 902-909.
24. Mandapati R, Skanes A, Chen J, Berenfeld O, Jalife J: Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation 2000; 101: 194-199.
25. Ha?̈ssaguerre M, Ja?̈s P, Shah DC et al: Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666.
26. Kirchhof P, Kahr PC, Kaese S et al: PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression. Circ Cardiovasc Genet 2011; 4: 123-133.
27. Chinchilla A, Daimi H, Lozano-Velasco E et al: PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis. Circ Cardiovasc Genet 2011; 4: 269-279.
28. Liu X, Wang F, Knight AC, Zhao J, Xiao J: Common variants for atrial fibrillation: results from genome-wide association studies. Hum Genet 2012; 131: 33-39.
29. Xiao J, Liang D, Chen Y-H: The genetics of atrial fibrillation: from the bench to the bedside. Annu Rev Genomics Hum Genet 2011; 12: 73-96.
30. Ido A, Miura Y, Watanabe M et al: Cloning of the cDNA encoding the mouse ATBF1 transcription factor. Gene 1996; 168: 227-231.
31. Ozgen N, Dun W, Sosunov EA et al: Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2 channels to membrane sites. Cardiovasc Res 2007; 75: 758-769.
32. Gratton J-P, Bernatchez P, Sessa WC: Caveolae and caveolins in the cardiovascular system. Circ Res 2004; 94: 1408-1417.
33. Zhao Y-Y, Liu Y, Stan R-V et al: Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci USA 2002; 99: 11375-11380.
34. Pfeufer A, Van Noord C, Marciante KD et al: Genome-wide association study of PR interval. Nat Genet 2010; 42: 153-159.
35. Ihida-Stansbury K, McKean DM, Gebb SA et al: Paired-related homeobox gene Prx1 is required for pulmonary vascular development. Circ Res 2004; 94: 1507-1514.
36. Mellad JA, Warren DT, Shanahan CM: Nesprins LINC the nucleus and cytoskeleton. Curr Opin Cell Biol 2011; 23: 47-54.
37. Zhang Q, Bethmann C, Worth NF et al: Nesprin-1 and-2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Hum Mol Genet 2007; 16: 2816-2833.
38. Herrmann S, Layh B, Ludwig A: Novel insights into the distribution of cardiac HCN channels: an expression study in the mouse heart. J Mol Cell Cardiol 2011; 51: 997-1006.
39. Schulze-Bahr E, Neu A, Friederich P et al: Pacemaker channel dysfunction in a patient with sinus node disease. J Clin Invest 2003; 111: 1537-1545.
40. Milanesi R, Baruscotti M, Gnecchi-Ruscone T, DiFrancesco D: Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. N Engl J Med 2006; 354: 151-157.
41. Beqqali A, Monshouwer-Kloots J, Monteiro R et al: CHAP is a newly identified Z-disc protein essential for heart and skeletal muscle function. J Cell Sci 2010; 123:Pt 7 1141-1150.
42. Brugada R, Tapscott T, Czernuszewicz GZ et al: Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997; 336: 905-911.
43. Holm H, Gudbjartsson DF, Sulem P et al: A rare variant in MYH6 is associated with high risk of sick sinus syndrome. Nat Genet 2011; 43: 316-320.
44. Nattel S: New ideas about atrial fibrillation 50 years on. Nature 2002; 415: 219-226.
45. Moe GK: Evidence for reentry as a mechanism of cardiac arrhythmias. Rev Physiol Biochem Pharmacol 1975; 72: 55-81.
46. Yang Y, Li J, Lin X et al: Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation. J Hum Genet 2009; 54: 277-283.
47. Shiroshita-Takeshita A, Brundel BJJM, Nattel S: Atrial fibrillation: basic mechanisms, remodeling and triggers. J Interv Card Electrophysiol 2005; 13: 181-193.
48. Chen Y-H, Xu S-J, Bendahhou S et al: KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003; 299: 251-254.
49. Hong K, Piper DR, Diaz-Valdecantos A et al: De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res 2005; 68: 433-440.
50. Das S, Makino S, Melman YF et al: Mutation in the S3 segment of KCNQ1 results in familial lone atrial fibrillation. Heart Rhythm 2009; 6: 1146-1153.
51. Bartos DC, Duchatelet S, Burgess DE et al: R231C mutation in KCNQ1 causes long QT syndrome type 1 and familial atrial fibrillation. Heart Rhythm 2011; 8: 48-55.
52. Abraham RL, Yang T, Blair M, Roden DM, Darbar D: Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation. J Mol Cell Cardiol 2010; 48: 181-190.
53. Otway R, Vandenberg JI, Guo G et al: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? J Am Coll Cardiol 2007; 49: 578-586.
54. Bartos DC, Anderson JB, Bastiaenen R et al: A KCNQ1 mutation causes a high penetrance for familial atrial fibrillation. J Cardiovasc Electrophysiol 2012; 24: 562-569.
55. Olesen MS, Bentzen BH, Nielsen JB et al: Mutations in the potassium channel subunit KCNE1 are associated with early-onset familial atrial fibrillation. BMC Med Genet 2012; 13: 24.
56. Yang Y, Xia M, Jin Q et al: Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004; 75: 899-905.
57. Mann SA, Otway R, Guo G et al: Epistatic effects of potassium channel variation on cardiac repolarization and atrial fibrillation risk. J Am Coll Cardiol 2012; 59: 1017-1025.
58. Hong K, Bjerregaard P, Gussak I, Brugada R, Short QT: syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol 2005; 16: 394-396.
59. Brugada R, Hong K, Dumaine R et al: Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2004; 109: 30-35.
60. Xia M, Jin Q, Bendahhou S et al: A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun 2005; 332: 1012-1019.
61. Delaney JT, Muhammad R, Blair MA et al: A KCNJ8 mutation associated with early repolarization and atrial fibrillation. Europace 2012; 14: 1428-1432, European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
62. Medeiros-Domingo A, Tan B-H, Crotti L et al: Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes. Heart Rhythm 2010; 7: 1466-1471.
63. Olson TM, Alekseev AE, Liu XK et al: Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet 2006; 15: 2185-2191.
64. Yang Y, Lin X, Li J, Chen Y: [Identification and functional analysis of a KCNA5 mutation responsible for idiopathic atrial fibrillation]. Zhonghua Yi Xue Za Zhi 2010; 90: 1100-1104.
65. Yang T, Yang P, Roden DM, Darbar D: Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation. Heart Rhythm 2010; 7: 1246-1252.
66. Christophersen IE, Olesen MS, Liang B et al: Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillation. Eur Heart J 2012; 34: 1517-1525.
67. Olson TM, Alekseev AE, Moreau C et al: KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation. Nat Clin Pract Cardiovasc Med 2007; 4: 110-116.
68. Darbar D, Kannankeril PJ, Donahue BS et al: Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation 2008; 117: 1927-1935.
69. Olesen MS, Yuan L, Liang B et al: High prevalence of long QT syndrome associated SCN5A variants in patients with early-onset lone atrial fibrillation. Circ Cardiovasc Genet 2012; 5: 450-459.
70. Watanabe H, Darbar D, Kaiser DW et al: Mutations in sodium channel beta1-and beta2-subunits associated with atrial fibrillation. Circ Arrhythm Electrophysiol 2009; 2: 268-275.
71. Wang P, Yang Q, Wu X et al: Functional dominant-negative mutation of sodium channel subunit gene SCN3B associated with atrial fibrillation in a Chinese GeneID population. Biochem Biophys Res Commun 2010; 398: 98-104.
72. Olesen MS, Jespersen T, Nielsen JB et al: Mutations in sodium channel b-subunit SCN3B are associated with early-onset lone atrial fibrillation. Cardiovasc Res 2011; 89: 786-793.
73. Hu D, Barajas-Martinez H, Burashnikov E et al: A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ Cardiovasc Genet 2009; 2: 270-278.
74. Olesen MS, Holst AG, Svendsen JH, Haunsø S, Tfelt-Hansen J: SCN1Bb R214Q found in 3 patients: 1 with Brugada syndrome and 2 with lone atrial fibrillation. Heart Rhythm 2012; 9: 770-773.
75. Hu D, Barajas-Mart?́nez H, Medeiros-Domingo A et al: A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. Heart Rhythm 2012; 9: 760-769.
76. Zhang X, Yang H, Corydon MJ et al: Localization of a human nucleoporin 155 gene (NUP155) to the 5p13 region and cloning of its cDNA. Genomics 1999; 57: 144-151.
77. Oberti C, Wang L, Li L et al: Genome-wide linkage scan identifies a novel genetic locus on chromosome 5p13 for neonatal atrial fibrillation associated with sudden death and variable cardiomyopathy. Circulation 2004; 110: 3753-3759.
78. Zhang X, Chen S, Yoo S et al: Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death. Cell 2008; 135: 1017-1027.
79. Epstein FH, Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 1998; 339: 321-328.
80. Hodgson-Zingman DM, Karst ML, Zingman LV et al: Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med 2008; 359: 158-165.
81. Zhang Y, Rath N, Hannenhalli S et al: GATA and Nkx factors synergistically regulate tissue-specific gene expression and development in vivo. Development 2007; 134: 189-198.
82. Posch MG, Boldt L-H, Polotzki M et al: Mutations in the cardiac transcription factor GATA4 in patients with lone atrial fibrillation. Eur J Med Genet 2010; 53: 201-203.
83. Yang Y-Q, Wang M-Y, Zhang X-L et al: GATA4 loss-of-function mutations in familial atrial fibrillation. Clin Chim Acta 2011; 412: 1825-1830.
84. Jiang J-Q, Shen F-F, Fang W-Y, Liu X, Yang Y-Q: Novel GATA4 mutations in lone atrial fibrillation. Int J Mol Med 2011; 28: 1025-1032.
85. Wang J, Sun Y-M, Yang Y-Q: Mutation spectrum of the GATA4 gene in patients with idiopathic atrial fibrillation. Mol Biol Rep 2012; 39: 8127-8135.
86. Yang Y-Q, Wang X-H, Tan H-W, Jiang W-F, Fang W-Y, Liu X: Prevalence and spectrum of GATA6 mutations associated with familial atrial fibrillation. Int J Cardiol 2012; 155: 494-496.
87. Yang Y-Q, Li L, Wang J et al: GATA6 loss-of-function mutation in atrial fibrillation. Eur J Med Genet 2012; 55: 520-526.
88. Li J, Liu W-D, Yang Z-L, Yang Y-Q: Novel GATA6 loss-of-function mutation responsible for familial atrial fibrillation. Int J Mol Med 2012; 55: 520-526.
89. Holaska JM: Emerin and the nuclear lamina in muscle and cardiac disease. Circ Res 2008; 103: 16-23.
90. Beckmann BM, Holinski-Feder E, Walter MC et al: Laminopathy presenting as familial atrial fibrillation. Int J Cardiol 2010; 145: 394-396.
91. Saj M, Dabrowski R, Labib S et al: Variants of the lamin A/C (LMNA) gene in non-valvular atrial fibrillation patients: a possible pathogenic role of the Thr528Met mutation. Mol Diagn Ther 2012; 16: 99-107.
92. Mü ller II, Melville DB, Tanwar V et al: Functional modeling in zebrafish demonstrates that the atrial-fibrillation-associated gene GREM2 regulates cardiac laterality, cardiomyocyte differentiation and atrial rhythm. Dis Model Mech 2012; 6: 332-341.
93. Thibodeau IL, Xu J, Li Q et al: Paradigm of genetic mosaicism and lone atrial fibrillation: physiological characterization of a connexin 43-deletion mutant identified from atrial tissue. Circulation 2010; 122: 236-244.
94. Gollob MH, Jones DL, Krahn AD et al: Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 2006; 354: 2677-2688.
95. Christophersen IE, Holmegard HN, Jabbari J et al: Rare variants in GJA5 are associated with early-onset lone atrial fibrillation. Can J Cardiol 2012; 29: 111-116.
96. Yang Y-Q, Liu X, Zhang X-L et al: Novel connexin40 missense mutations in patients with familial atrial fibrillation. Europace 2010; 12: 1421-1427.
97. Yang Y-Q, Zhang X-L, Wang X-H et al: Connexin40 nonsense mutation in familial atrial fibrillation. Int J Mol Med 2010; 26: 605-610.
98. Sun Y, Yang Y-Q, Gong X-Q et al: Novel germline GJA5/connexin40 mutations associated with lone atrial fibrillation impair gap junctional intercellular communication. Hum Mutat 2013; 34: 603-609.
99. Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP), Seattle, WA, USA (URL. http://evs.gs.washington.edu/EVS/) Accessed 1 February 2013
100. Refsgaard L, Holst AG, Sadjadieh G, Haunsø S, Nielsen JB, Olesen MS: High prevalence of genetic variants previously associated with LQT syndrome in new exome data. Eur J Hum Genet 2012; 20: 905-908.
101. Andreasen C, Refsgaard L, Nielsen BN et al: Mutations in genes encoding cardiac ion channels previously associated with sudden infant death syndrome (SIDS) are present with high frequency in new exome data. Can J Cardiol, S0828-282X: 01514-0.
102. Andreasen C, Nielsen JB, Refsgaard L et al: New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants. Eur J Hum Genet 2013; 21: 918-928.
103. Risgaard B, Jabbari R, Refsgaard L et al: High prevalence of genetic variants previously associated with Brugada syndrome in new exome data. Clin Genet 2013; doi:10.1111/cge.12126.
104. Hedley PL, Jørgensen P, Schlamowitz S et al: The genetic basis of long QT and short QT syndromes: a mutation update. Hum Mutat 2009; 30: 1486-1511.
105. Ohno S, Toyoda F, Zankov DP et al: Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome. Hum Mutat 2009; 30: 557-563.
106. Delpón E, Cordeiro JM, Núñ ez L et al: Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol 2008; 1: 209-218.
107. Ohno S, Zankov DP, Ding W-G et al: KCNE5 (KCNE1L) variants are novel modulators of Brugada syndrome and idiopathic ventricular fibrillation. Circ Arrhythm Electrophysiol 2011; 4: 352-361.
108. Giudicessi JR, Ye D, Tester DJ et al: Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. Heart Rhythm 2011; 8: 1024-1032.
109. Wilders R, Verkerk AO: Role of the R1135H KCNH2 mutation in Brugada syndrome. Int J Cardiol 2010; 144: 149-151.
110. Hedley PL, Jørgensen P, Schlamowitz S et al: The genetic basis of Brugada syndrome: a mutation update. Hum Mutat 2009; 30: 1256-1266.
111. Ishikawa T, Takahashi N, Ohno S et al: Novel SCN3B mutation associated with Brugada syndrome affects intracellular trafficking and function of Nav1.5. Circ J 2012; 77: 959-967.
112. Bienengraeber M, Olson TM, Selivanov VA et al: ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet 2004; 36: 382-387.
113. Disertori M, Quintarelli S, Grasso M et al: Autosomal recessive atrial dilated cardiomyopathy with standstill evolution associated with mutation of natriuretic peptide precursor A. Circ Cardiovasc Genet 2013; 6: 27-36.
114. Johnson JN, Tester DJ, Perry J, Salisbury BA, Reed CR, Ackerman MJ: Prevalence of early-onset atrial fibrillation in congenital long QT syndrome. Heart Rhythm 2008; 5: 704-709.
115. Giustetto C, Schimpf R, Mazzanti A et al: Long-term follow-up of patients with short QT syndrome. J Am Coll Cardiol 2011; 58: 587-595.
116. Nielsen JB, Graff C, Pietersen A et al: J-shaped association between QTc interval duration and the risk of atrial fibrillation: results from the Copenhagen ECG Study. J Am Coll Cardiol 2013; S0735-1097: 01412-01415.
117. Ritchie MD, Rowan S, Kucera G et al: Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation. J Am Coll Cardiol 2012; 60: 1173-1181.
118. Olesen MS, Refsgaard L, Holst AG et al: A novel KCND3 gain-of-function mutation associated with early-onset of persistent lone atrial fibrillation. Cardiovasc Res 2013; 98: 488-495.
119. Ackerman MJ, Priori SG, Willems S et al: HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 2011; 8: 1308-1339.
120. Everett BM, Cook NR, Conen D, Chasman DI, Ridker PM, Albert CM: Novel genetic markers improve measures of atrial fibrillation risk prediction. Eur Heart J 2013.
121. Fodstad H, Bendahhou S, Rougier J-S et al: Molecular characterization of two founder mutations causing long QT syndrome and identification of compound heterozygous patients. Ann Med 2006; 38: 294-304.
122. Arnestad M, Crotti L, Rognum TO et al: Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation 2007; 115: 361-367.
123. Ackerman MJ, Siu BL, Sturner WQ et al: Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 2001; 286: 2264-2269.
124. Olson TM, Michels VV, Ballew JD et al: Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 2005; 293: 447-454.
125. Li Q, Huang H, Liu G et al: Gain-of-function mutation of Nav1.5 in atrial fibrillation enhances cellular excitability and lowers the threshold for action potential firing. Biochem Biophys Res Commun 2009; 380: 132-137.
126. Makiyama T, Akao M, Shizuta S et al: A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. J Am Coll Cardiol 2008; 52: 1326-1334.
127. Ellinor PT, Nam EG, Shea MA, Milan DJ, Ruskin JN, MacRae CA: Cardiac sodium channel mutation in atrial fibrillation. Heart Rhythm 2008; 5: 99-105.
128. Brauch KM, Chen LY, Olson TM: Comprehensive mutation scanning of LMNA in 268 patients with lone atrial fibrillation. Am J Cardiol 2009; 103: 1426-1428.